When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.
Now, Vertex may be on the move again.
advertisement
With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
Ozempic cut risk of death in diabetes patients with chronic kidney disease
Next article： Drug repurposing or repositioning? The language matters
Next article： Drug repurposing or repositioning? The language matters
